Literature DB >> 29037437

The Australian Royal Commission into Institutional Responses to Child Sexual Abuse.

Katie Wright1, Shurlee Swain2, Kathleen McPhillips3.   

Abstract

The Royal Commission into Institutional Responses to Child Sexual Abuse is the largest royal commission in Australia's history and one of the largest public inquiries into institutional child abuse internationally. With an investment from the Australian government of half a billion dollars, it examined how institutions with a responsibility for children, both historically and in the present, have responded to allegations of child sexual abuse. Announced in the wake of previous Australian and international inquiries, public scandals and lobbying by survivor groups, its establishment reflected increasing recognition of the often lifelong and intergenerational damage caused by childhood sexual abuse and a strong political commitment to improving child safety and wellbeing in Australia. This article outlines the background, key features and innovations of this landmark public inquiry, focusing in particular on its extensive research program. It considers its international significance and also serves as an introduction to this special edition on the Australian Royal Commission, exploring its implications for better understanding institutional child sexual abuse and its impacts, and for making institutions safer places for children in the future.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Australia; Child sexual abuse; Institutional child abuse; Public inquiries; Royal Commission into Institutional Responses to Child Sexual Abuse; Royal commissions

Mesh:

Year:  2017        PMID: 29037437     DOI: 10.1016/j.chiabu.2017.09.031

Source DB:  PubMed          Journal:  Child Abuse Negl        ISSN: 0145-2134


  1 in total

Review 1.  The Integration of People Convicted of a Sexual Offence Into the Community and Their (Risk) Management.

Authors:  K F McCartan; K Richards
Journal:  Curr Psychiatry Rep       Date:  2021-07-01       Impact factor: 5.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.